ClinicalTrials.gov
public full text
Public Domain
Efficacy of Fluoxetine - a Trial in Stroke
The purpose of this study is to investigate whether routine administration of fluoxetine 20mg once daily in the 6 months initiated during the acute stroke improves the patient's functional outcome. EFFECTS is an investigator lead Sweden-based, multicenter, parallel group, double blind placebo controlled trial with broad entry criteria and follow up at 6 and 12 months. EFFECTS managed to recruit its anticipated numbers of 1,500 participants between 20th October 2014 and 28th June 2019. Data will be unblinded when the 6-months follow-up is completed, and the primary outcome is due to report on May 2020.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Stroke Research Consortium in Northern Bavaria (STAMINA)#801926
- Data Sheet 1_Systematic review and meta-analysis of the effectiveness of non-pharmacological interventions in restoring lower limb motor function after stroke.pdf#1079174
- Improving Primary Care After Stroke (IPCAS)#1088110
- Helping Ease Anxiety and Depression Following Stroke Stage 3#835785
- Effects on Clinical and Functional Outcome of Escitalopram in Adult Stroke Patients#1060385
Record · ID 1113255
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive